🔬Cell & Gene Therapy
Living cell-based treatments including CAR-T, stem cells, and engineered immune cells for cancer and genetic diseases.
Market Cap$1.2T
1D-0.79%
Companies772
Public Cos100
SECTOR MARKET CAP
$1.2T+3776.7%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $534.2B | JNJ |
| 2 |  | Switzerland | $278.1B | NVS |
| 3 |  | United States | $114.0B | BMY |
| 4 |  | United Kingdom | $100.7B | GSK |
| 5 |  | Switzerland | $43.5B | LONN.SW |
| 6 |  | Japan | $26.3B | 4503.T |
| 7 |  | China | $17.9B | WXXWY |
| 8 |  | United States | $10.5B | BMRN |
| 9 |  | United States | $8.8B | KRYS |
| 10 |  | United States | $8.1B | IBRX |
| 11 |  | United States | $7.3B | 950160.KQ |
| 12 |  | United States | $2.1B | SRPT |
| 13 |  | United States | $1.9B | TSHA |
| 14 |  | United States | $1.7B | CAPR |
| 15 |  | United States | $1.7B | VCEL |
| 16 |  | United States | $1.6B | 2171.HK |
| 17 |  | United States | $1.5B | IOVA |
| 18 |  | Netherlands | $1.5B | QURE |
| 19 |  | Germany | $1.5B | IMTX |
| 20 |  | United States | $1.5B | PGEN |